vs

Side-by-side financial comparison of FIREFLY NEUROSCIENCE, INC. (AIFF) and Xiao-I Corp (AIXI). Click either name above to swap in a different company.

Xiao-I Corp is the larger business by last-quarter revenue ($11.5M vs $412.0K, roughly 28.0× FIREFLY NEUROSCIENCE, INC.). Xiao-I Corp runs the higher net margin — -263.9% vs -601.9%, a 338.1% gap on every dollar of revenue.

Firefly Neuroscience Inc. is a clinical-stage biotechnology firm focused on developing non-invasive neuromodulation therapies for neuropsychiatric and neurodegenerative disorders. Its lead products target conditions including major depressive disorder and cognitive impairment, with core operations and initial market focus in North America.

Xiao-i is a Chinese cognitive artificial intelligence enterprise founded in 2001.

AIFF vs AIXI — Head-to-Head

Bigger by revenue
AIXI
AIXI
28.0× larger
AIXI
$11.5M
$412.0K
AIFF
Higher net margin
AIXI
AIXI
338.1% more per $
AIXI
-263.9%
-601.9%
AIFF

Income Statement — Q4 2025 vs Q3 2025

Metric
AIFF
AIFF
AIXI
AIXI
Revenue
$412.0K
$11.5M
Net Profit
$-2.5M
$-30.4M
Gross Margin
58.1%
Operating Margin
-607.0%
-254.9%
Net Margin
-601.9%
-263.9%
Revenue YoY
677.4%
Net Profit YoY
34.5%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIFF
AIFF
AIXI
AIXI
Q4 25
$412.0K
Q3 25
$388.0K
$11.5M
Q2 25
$299.0K
$11.5M
Q1 25
$43.0K
Q4 24
$53.0K
Q3 24
$33.0K
Q2 24
$10.0K
$33.0M
Q1 24
$12.0K
Net Profit
AIFF
AIFF
AIXI
AIXI
Q4 25
$-2.5M
Q3 25
$-2.6M
$-30.4M
Q2 25
$-1.8M
$-30.4M
Q1 25
$-12.9M
Q4 24
$-3.8M
Q3 24
$-4.3M
Q2 24
$-1.3M
$-15.5M
Q1 24
$-1.1M
Gross Margin
AIFF
AIFF
AIXI
AIXI
Q4 25
Q3 25
37.6%
58.1%
Q2 25
91.6%
58.1%
Q1 25
Q4 24
-1196.7%
Q3 24
100.0%
Q2 24
100.0%
64.5%
Q1 24
Operating Margin
AIFF
AIFF
AIXI
AIXI
Q4 25
-607.0%
Q3 25
-684.5%
-254.9%
Q2 25
-546.5%
-254.9%
Q1 25
-4802.3%
Q4 24
-6483.0%
Q3 24
-12933.3%
Q2 24
-12590.0%
-45.0%
Q1 24
-9091.7%
Net Margin
AIFF
AIFF
AIXI
AIXI
Q4 25
-601.9%
Q3 25
-680.2%
-263.9%
Q2 25
-613.0%
-263.9%
Q1 25
-30069.8%
Q4 24
-7141.5%
Q3 24
-12997.0%
Q2 24
-12640.0%
-47.2%
Q1 24
-9350.0%
EPS (diluted)
AIFF
AIFF
AIXI
AIXI
Q4 25
Q3 25
$-0.20
Q2 25
Q1 25
Q4 24
Q3 24
$-0.61
Q2 24
$-0.58
$-0.64
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIFF
AIFF
AIXI
AIXI
Cash + ST InvestmentsLiquidity on hand
$5.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$7.6M
Total Assets
$10.5M
$82.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIFF
AIFF
AIXI
AIXI
Q4 25
Q3 25
$5.0M
Q2 25
$5.0M
Q1 25
Q4 24
Q3 24
Q2 24
$244.1K
$1.8M
Q1 24
$563.3K
Stockholders' Equity
AIFF
AIFF
AIXI
AIXI
Q4 25
$7.6M
Q3 25
$9.7M
Q2 25
$12.1M
Q1 25
$5.2M
Q4 24
$-375.0K
Q3 24
$-2.8M
Q2 24
$-1.2M
Q1 24
$-9.0K
Total Assets
AIFF
AIFF
AIXI
AIXI
Q4 25
$10.5M
Q3 25
$12.4M
$82.4M
Q2 25
$14.9M
$82.4M
Q1 25
$12.4M
Q4 24
$4.6M
Q3 24
$5.3M
Q2 24
$3.3M
$87.6M
Q1 24
$3.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIFF
AIFF
AIXI
AIXI
Operating Cash FlowLast quarter
$-1.8M
$-2.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIFF
AIFF
AIXI
AIXI
Q4 25
$-1.8M
Q3 25
$-1.5M
$-2.3M
Q2 25
$-2.4M
$-2.3M
Q1 25
$-2.5M
Q4 24
$-1.2M
Q3 24
$-2.5M
Q2 24
$-1.1M
Q1 24
$-1.3M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons